447.92
Alnylam Pharmaceuticals Inc (ALNY) 最新ニュース
Alnylam receives subpoena from US Attorney's Office amid strong Q3 earnings - The Business Journals
Alnylam (ALNY) Reports Strong Q3 Revenues and Raises Future Guidance - GuruFocus
Compared to Estimates, Alnylam (ALNY) Q3 Earnings: A Look at Key Metrics - Yahoo! Finance Singapore
Alnylam Pharmaceuticals, Inc. Revises Earnings Guidance for the Year 2025 - MarketScreener
Alnylam Pharmaceuticals : Q3 2025 Earnings Presentation - MarketScreener
Alnylam Pharmaceuticals Surpasses Q3 2025 Estimates with $1.84 E - GuruFocus
Alnylam Pharma shares fall 4% despite strong Q3 results and raised guidance - Investing.com Canada
Alnylam Pharmaceuticals Swings to Q3 Non-GAAP Earnings, Revenue Increases - MarketScreener
Alnylam: Q3 Earnings Snapshot - News-Times
ALNYLAM PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress - Business Wire
Why global investors buy Alnylam Pharmaceuticals Inc. (DUL) stockWeekly Stock Analysis & AI Optimized Trading Strategy Guides - newser.com
How dovish Fed policy supports Alnylam Pharmaceuticals Inc. (DUL) stock2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Is Alnylam Pharmaceuticals Inc. reversing from oversold territoryProduct Launch & Reliable Entry Point Alerts - newser.com
Alnylam Pharmaceuticals, Inc. $ALNY Shares Bought by Teacher Retirement System of Texas - MarketBeat
Combining machine learning predictions for Alnylam Pharmaceuticals Inc.Trade Risk Summary & Technical Buy Zone Confirmations - newser.com
How to recover losses in Alnylam Pharmaceuticals Inc. stockPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com
Is Alnylam Pharmaceuticals Inc. (DUL) stock vulnerable to rate hikesWatch List & Free Expert Verified Stock Movement Alerts - newser.com
Amgen's Q3 Earnings in the Cards: Here's What to Expect - The Globe and Mail
How Recent Momentum and Analyst Upgrades Are Shaping Alnylam’s Evolving Investment Story - Yahoo Finance
How to monitor Alnylam Pharmaceuticals Inc. with trend dashboardsQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
What data driven models say about Alnylam Pharmaceuticals Inc.’s futureJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com
RNAi Technology Market See Incredible Growth 2025-2032 | Alnylam Pharmaceuticals, OriGene Technologies, Inc. - openPR.com
Motley Fool Asset Management LLC Grows Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. $ALNY Shares Acquired by Wealthfront Advisers LLC - MarketBeat
Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain revenue momentumPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
How risky is Alnylam Pharmaceuticals Inc. (DUL) stock compared to peersJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Will Alnylam Pharmaceuticals Inc. continue its uptrendJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
What RSI levels show for Alnylam Pharmaceuticals Inc. (DUL) stock2025 Market WrapUp & Accurate Trade Setup Notifications - newser.com
PD-1 and PD-L1 Inhibitors Clinical Landscape, Key Companies, Therapeutic Evaluation, Treatment Approaches, and Pipeline Insights | Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals - Barchart.com
Bevacizumab: Clinical Overview, Key Companies, Therapeutic Insights, Treatment Strategies, and Pipeline Analysis | Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals, Neuvivo, BPG B - Barchart.com
Why Alnylam Pharmaceuticals Inc. stock is recommended by analystsWeekly Trend Summary & Comprehensive Market Scan Insights - newser.com
Is Alnylam Pharmaceuticals Inc. stock dividend yield sustainableQuarterly Earnings Report & Weekly High Conviction Trade Ideas - Fundação Cultural do Pará
Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPS - Yahoo! Finance UK
Hypertension Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Addpharma Inc., Alnylam Therapeutics, ORPHAI THERAPEUTICS, 35Pharma Inc - Barchart.com
Alnylam Pharmaceuticals (ALNY) extending rally in final stage from April-2025 low - FXStreet
What downside risks could hit Alnylam Pharmaceuticals Inc. (DUL) stock2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
Convergence Investment Partners LLC Acquires New Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain institutional flows2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Is it time to cut losses on Alnylam Pharmaceuticals Inc.Treasury Yields & Smart Investment Allocation Insights - newser.com
What to do if you’re stuck in Alnylam Pharmaceuticals Inc.Trade Ideas & Weekly Top Gainers Trade List - newser.com
大文字化:
|
ボリューム (24 時間):